Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...
Catalyst Pharmaceuticals' Firdapse delivers strong growth with a 37% CAGR. Click here to find out why CPRX stock is a Hold.
11h
Stockhead on MSNDr Boreham’s Crucible: This MSA-tackling biotech strives to be ‘different’Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will attend the Leerink Global ...
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...
New York, New York-- (Newsfile Corp. - March 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Crocs, Inc. (NASDAQ: CROX) and certain of ...
New York, New York-- (Newsfile Corp. - March 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Soho House & Co. Inc. (NYSE: SHCO), the board of ...
Deckers Outdoor stock drops 39% after Q3 report. Read here for insights on HOKA's growth, UGG's momentum, and challenges ...
Especially now when then government of Ghana, and in fulfilment of a pledge by President John Dramani Mahama to reduce fares ...
Vaginitis Treatment Drug MarketThe global vaginitis treatment drug market is projected to grow from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, expanding at a CAGR of 4.8%. This growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results